Clinical Outcomes after Proton Partial-Breast Radiotherapy for Early-Stage, Hormone Receptor-Positive Breast Cancer: 3-Year Outcomes of a Phase II Trial

被引：3
|
作者：
Choi, I. J. [1 ]
Prabhu, K., Jr. [2 ]
Hartsell, W. F. [3 ]
Sinesi, C. C. [4 ]
Vargas, C. E. [5 ,6 ]
Benda, R. K. [7 ]
Cahlon, O. [8 ]
Chang, A. L. [9 ]
机构：
[1] New York Proton Ctr, New York, NY USA
[2] Procure Proton Therapy Ctr, Oklahoma City, OK USA
[3] Northwestern Med Chicago Proton Ctr, Warrenville, IL USA
[4] Hampton Univ, Proton Therapy Inst, Hampton, VA 23668 USA
[5] Mayo Clin, Scottsdale, AZ USA
[6] Mayo Clin Arizona, Dept Radiat Oncol, Phoenix, AZ USA
[7] Boca Raton Reg Hosp, Boca Raton, FL USA
[8] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[9] Calif Protons Canc Therapy Ctr, San Diego, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2042
引用
收藏
页码：E19 / E19
页数：1
相关论文
共 50 条
  • [21] Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review
    Melika Shirdarreh
    Rossanna C. Pezo
    Breast Cancer, 2021, 28 : 755 - 764
  • [22] Locoregional Therapy Patterns in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer
    Nguyen, Kenny
    Hersh, Eliza H.
    Chen, Yu-Jen
    King, Tari
    Mittendorf, Elizabeth
    Minami, Christina A.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S87 - S88
  • [23] Risk Factors for Fat Necrosis after Stereotactic Partial-Breast Irradiation (S-PBI) for Early-Stage Breast Cancer on a Phase I Clinical Trial
    Rahimi, A. S.
    Zhang, Y.
    Hossain, F.
    Spangler, A. E.
    Kim, D. N.
    Leitch, M.
    Wooldridge, R.
    Ahn, C.
    Zhao, B.
    Haley, B.
    Rao, R.
    Rivers, A.
    Gu, X.
    Timmerman, R. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E63 - E63
  • [24] Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer
    Downs-Canner, Stephanie M.
    Gaber, Charles E.
    Louie, Raphael J.
    Strassle, Paula D.
    Gallagher, Kristalyn K.
    Muss, Hyman B.
    Ollila, David W.
    CANCER, 2020, 126 (06) : 1193 - 1201
  • [25] Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review
    Shirdarreh, Melika
    Pezo, Rossanna C.
    BREAST CANCER, 2021, 28 (03) : 755 - 764
  • [26] Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer
    Warren, Stephanie L.
    Bhutiani, Neal
    Agle, Steven C.
    Martin, Robert C. G., II
    McMasters, Kelly M.
    Ajkay, Nicolas
    AMERICAN JOURNAL OF SURGERY, 2018, 216 (02): : 326 - 330
  • [27] The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer
    Ozveren, Ahmet
    Ridvanogullari Donger, Melis
    Motor, Sedat
    Bulut, Gulcan
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [28] The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer
    Jain, Sarika
    Santa-Maria, Cesar Augusto
    Gradishar, William J.
    ONCOLOGY-NEW YORK, 2015, 29 (07): : 473 - +
  • [29] Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer
    Wilson, Sheridan
    Speers, Caroline
    Tyldesley, Scott
    Chia, Stephen
    Kennecke, Hagen
    Ellard, Susan
    Lohrisch, Caroline
    CLINICAL BREAST CANCER, 2016, 16 (04) : 284 - 290
  • [30] Impact of young age on local control after partial-breast irradiation in early-stage breast cancer
    Sato, K.
    Mizuno, Y.
    Fuchikami, H.
    Takeda, N.
    Kato, M.
    CANCER RESEARCH, 2016, 76
12345